Figure 1.
New therapies in AD treatment and their respective targets. (Triangle arrowhead representing next step in mechanism. Arrow with horizontal line represents inhibition. Abbreviations: AhR: aryl hydrocarbon receptor; IL: interleukin; JAK: janus kinase; PDE-4: phosphodiesterase 4, Th2: T helper 2, TRPV1: transient receptor potential vanilloid subfamily V member 1).
